Navigation Links
National Event Addresses Breakthroughs in Crohn's & Colitis Research: National Expert & Researcher Answers Key Questions on Interactive Webcast/Teleconference
Date:3/9/2010

Research in inflammatory bowel diseases (IBD) is changing and improving the way Crohn’s disease and ulcerative colitis—chronic and often debilitating digestive diseases impacting 1.4 million Americans—are diagnosed and treated. On Tuesday, March 30, at 1 PM ET , Crohn’s and colitis patients, families, and caregivers can tune into a Crohn’s & Colitis Foundation of America (CCFA) interactive educational webcast/teleconference entitled, “Breakthroughs in IBD Research: Helping You Today.” National expert and researcher Stephan R. Targan, MD, Director of the Inflammatory Bowel and Immunobiology Research Institute at Cedars-Sinai Medical Center, will discuss recent advances in IBD research and answer audience questions during an interactive question and answer session.

New York, NY (Vocus) -- Research in inflammatory bowel diseases (IBD) is changing and improving the way Crohn’s disease and ulcerative colitis—chronic and often debilitating digestive diseases impacting 1.4 million Americans—are diagnosed and treated. On Tuesday, March 30, at 1 PM ET , Crohn’s and colitis patients, families, and caregivers can tune into a Crohn’s & Colitis Foundation of America (CCFA) interactive educational webcast/teleconference entitled, “Breakthroughs in IBD Research: Helping You Today.” National expert and researcher Stephan R. Targan, MD, Director of the Inflammatory Bowel and Immunobiology Research Institute at Cedars-Sinai Medical Center, will discuss recent advances in IBD research and answer audience questions during an interactive question and answer session

During the program, participants will receive insight into important questions about research in inflammatory bowel diseases including:
o   What is currently going on in research, how close are we to answers?
o   How will advances in IBD genetics and immunology impact me?
o   When should an infusion or injection therapy be considered in IBD treatment?
o   What are clinical trials and how can they benefit me?

Board certified in internal medicine, gastroenterology and infectious disease, Dr. Targan has been awarded investigative grants from the National Institutes of Health (NIH), CCFA’s Scientific Achievement Award for Clinical Science, as well as research contracts with numerous industry sponsors. His research has primarily focused on the genetic and immunopathologic mechanisms of inflammatory bowel disease.

"Research into Crohn’s disease and ulcerative colitis is rapidly advancing, allowing for better therapies for patients today and tomorrow,” says Dr. Targan. “Patients are asking how Crohn’s and colitis breakthroughs are going to impact their quality of life now and down the road, and the Crohn’s & Colitis Foundation’s March 30 teleconference will help answer these questions.”

Shire is sponsoring this event. Registration is available at no cost to participants via an online portal at www.ccfa.org/webcasts/research and by phone at 1-877-547-5641 ext. 312.

About Crohn’s Disease & Ulcerative Colitis
Crohn’s disease and ulcerative colitis are painful, medically incurable illnesses that attack the digestive system. Crohn’s disease may attack anywhere from the mouth to the anus, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever and weight loss. Many patients require hospitalization and surgery. These illnesses can cause severe complications, including colon cancer in patients with long-term disease. Some 1.4 million American adults and children suffer from Crohn’s disease or ulcerative colitis, with as many as 150,000 under the age of 18. Most people develop the diseases between the ages of 15 and 35.

About the Crohn’s & Colitis Foundation
The Crohn’s & Colitis Foundation of America’s mission is to cure Crohn’s disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 81 cents of every dollar the Foundation spends goes to mission-critical programs. The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau’s Wise Giving Alliance (give.org) and the American Institute of Philanthropy (charitywatch.org). For more information, contact the Foundation at 800-932-2423 or visit www.ccfa.org. Join CCFA on Facebook at http://apps.facebook.com/supportccfa/ and follow CCFA on Twitter at www.twitter.com/ccfa.

SHIRE PLC
Shire is a leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician, and focuses on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases. For further information on Shire, visit http://www.shire.com.

Media Contact:
Ariella Levine
1-646-943-7430
alevine(at)ccfa(dot)org

###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3705294.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. $250,000 Bioactive Beverage Challenge Announced By Tahitian Noni International
2. Latex Mattress Retailer Celebrates National Sleep Awareness Week with Pledge to Help Women and Kids in Shelters Sleep Better
3. Quantros Releases Video in Recognition of National Patient Safety Week
4. Diet and Healthy Weight Tips for National Nutrition Month from Patients Medical
5. National Prosthodontics Awareness Week Serves and Educates Consumers About Proper Oral Health Care
6. March is National Professional Social Work Month
7. St. Elizabeth Medical Residents to Present Research at International Meeting
8. National Climate Organizations Join Forces In Historic Push For Climate and Clean Energy Solutions
9. Blue Cross and Blue Shield Companies To Host Fourth Annual National Walk@Lunch Day(R) on April 28, 2010
10. Natures Peak Products Along With Company President Paul Wilkinson Were Recently Featured on Segment of Lifetime TV Networks Nationally Broadcast Show The Balancing Act
11. Christiana Care Health System Wins National Award for Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
National Event Addresses Breakthroughs in Crohn's & Colitis Research: National Expert & Researcher Answers Key Questions on Interactive Webcast/Teleconference
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... -- According to the Centers for Disease Control and Prevention (CDC), influenza ... Care is helping communities across Massachusetts , ... no-cost* flu shots through the end of the month. *Some ... ... flu shot is by the end of October, according to the Centers ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new low volume, ... 2017 in Cambridge, U.K on October 4th. ... samples with unprecedented speed and sensitivity while using far less sample ... ... system ...
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
Breaking Medicine Technology: